Solid Biosciences Inc (SLDB)
8.51
-0.61
(-6.69%)
USD |
NASDAQ |
May 21, 11:15
Solid Biosciences Total Assets (Quarterly): 248.69M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 248.69M |
December 31, 2023 | 164.94M |
September 30, 2023 | 184.73M |
June 30, 2023 | 204.72M |
March 31, 2023 | 229.59M |
December 31, 2022 | 260.25M |
September 30, 2022 | 184.47M |
June 30, 2022 | 208.50M |
March 31, 2022 | 207.56M |
December 31, 2021 | 232.38M |
September 30, 2021 | 248.99M |
June 30, 2021 | 265.86M |
March 31, 2021 | 285.28M |
December 31, 2020 | 171.17M |
Date | Value |
---|---|
September 30, 2020 | 40.52M |
June 30, 2020 | 57.96M |
March 31, 2020 | 73.96M |
December 31, 2019 | 103.47M |
September 30, 2019 | 130.93M |
June 30, 2019 | 96.30M |
March 31, 2019 | 120.23M |
December 31, 2018 | 139.60M |
September 30, 2018 | 156.81M |
June 30, 2018 | 171.47M |
March 31, 2018 | 189.24M |
December 31, 2017 | 76.19M |
September 30, 2017 | 35.44M |
December 31, 2016 | 40.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
40.52M
Minimum
Sep 2020
285.28M
Maximum
Mar 2021
180.01M
Average
194.72M
Median
Total Assets (Quarterly) Benchmarks
Sarepta Therapeutics Inc | 3.224B |
PTC Therapeutics Inc | 1.790B |
Capricor Therapeutics Inc | 49.44M |
Catalyst Pharmaceuticals Inc | 646.68M |
Pfizer Inc | 221.10B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 37.96M |
Shareholders Equity (Quarterly) | 210.72M |